---
document_datetime: 2023-09-21 19:56:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/truvada-epar-all-authorised-presentations_en.pdf
document_name: truvada-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7249806
conversion_datetime: 2025-12-27 10:05:45.627163
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/04/305/001   | Truvada   | 200 mg / 245 mg   | Film-coated tablet   | Oral use   | bottle (HDPE)   | 30 tablets          |
|-------------------|-----------|-------------------|----------------------|------------|-----------------|---------------------|
| EU/1/04/305/002   | Truvada   | 200 mg / 245 mg   | Film-coated tablet   | Oral use   | bottle (HDPE)   | 90 (3 x 30) tablets |
| EU/1/04/305/003   | Truvada   | 200 mg / 245 mg   | Film-coated tablet   | Oral use   | Bottle (HDPE)   | 60 (2 x 30) tablets |